Skip Navigation

Open Label Phase II Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03485209

Study #:
STUDY00142260

Start Date:
Dec 10, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03485209

View Complete Trial Details & Eligibility at ClinicalTrials.gov